Evidence map›Paper›PMID 33641565›Full record

ArticleJournal of enzyme inhibition and medicinal chemistry2021

Exposure of human intestinal epithelial cells and primary human hepatocytes to trypsin-like serine protease inhibitors with potential antiviral effect.

Erzsébet Pászti-Gere, Judit Pomothy, Ákos Jerzsele, Oliver Pilgram, Torsten Steinmetzer

Open access · goldAbstract read
In one paragraph

Article in Journal of enzyme inhibition and medicinal chemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Erzsébet Pászti-GereDepartment of Pharmacology and Toxicology, University of Veterinary Medicine, Budapest, Hungary.ORCID https://orcid.org/0000-0003-4073-7018
Judit PomothyDepartment of Pharmacology and Toxicology, University of Veterinary Medicine, Budapest, Hungary.ORCID https://orcid.org/0000-0001-6978-9626
Ákos JerzseleDepartment of Pharmacology and Toxicology, University of Veterinary Medicine, Budapest, Hungary.ORCID https://orcid.org/0000-0002-3380-0827
Oliver PilgramFaculty of Pharmacy, Institute of Pharmaceutical Chemistry, Philipps University Marburg, Marburg, Germany.ORCID https://orcid.org/0000-0002-6279-2491
Torsten SteinmetzerFaculty of Pharmacy, Institute of Pharmaceutical Chemistry, Philipps University Marburg, Marburg, Germany.ORCID https://orcid.org/0000-0001-6523-4754
University of Veterinary Medicine · HUPhilipps University of Marburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human intestinal epithelial cell line-6 (HIEC-6) cells and primary human hepatocytes (PHHs) were treated with 3-amidinophenylalanine-derived inhibitors of trypsin-like serine proteases for 24 hours. It was proven that treatment with MI-1900 and MI-1907 was tolerated up to 50 μM in HIEC-6. These inhibitors did not cause elevations in extracellular H

Indexed as

Antiviral AgentsCell LineCell SurvivalEpithelial CellsGene Expression RegulationHepatocytesHumansHydrogen PeroxideInterleukin-6Interleukin-8Intestinal MucosaOccludinOxidation-ReductionPhenylalaninePrimary Cell CultureProtease InhibitorsAntiviral AgentsHydrogen PeroxideIL6 protein, humanInterleukin-6Interleukin-8OccludinOCLN protein, humanPhenylalanineProtease InhibitorsSerine EndopeptidasesTMPRSS2 protein, humantrypsin-like serine proteaseH2O2HIEC-6occludinPHHtrypsin-like serine protease inhibitors

Identifiers

PMID33641565
PMCPMC7928042
OpenAlexW3135441833

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.